Best US Cannabis ETFs For 2022 Right Now
Best Marijuana ETFs In Q1 2022
Top Marijuana ETFs In January 2022
Are you looking for top marijuana stocks to buy before February 2022? In January many of the best cannabis stocks to invest in have established new lows to start the year. In general, this is mostly related to delays with federal marijuana legalization in the US. But these significant declines in value for top pot stocks could be an opportunity for cannabis investors in 2022.
Although cannabis stocks have not performed well in the market cannabis companies, have expanded rapidly across the US and sales have increased in many states that have already legalized medical or recreational use. Generally speaking, there are many leading cannabis company’s investors can choose from sometimes making it difficult to find the right marijuana stocks to buy in 2022.
But there are ways to invest in an area of top cannabis stocks. In general, marijuana ETFs could be a good way for an investor to gain exposure to a broader aspect of pot stocks in one trade. ETFs or an exchange-traded fund is a type of security that tracks an index, sector, commodity, or other asset and is bought and sold on the stock exchange like a regular stock. Some cannabis ETFs are focused on the US cannabis market while others are holding assets in the medicinal area of the cannabis industry.
Investing In ETFs And The Cannabis Industry In 2022
Regardless top marijuana ETFs also give the retail investor on the Robinhood Markets, Inc. (NASDAQ: HOOD) and WeBull platforms access to some of the top US marijuana stocks that trade on the OTC Markets. Because cannabis is still federally illegal US cannabis companies are unable to trade on the major US stock exchanges and trade on the OTC Markets not available to Robinhood and WeBull investors. Gaining access through a marijuana ETF could be a way to gain long-term exposure to the cannabis industry.
Before investing in cannabis ETFs, it’s important to do your own research and find the best companies for your portfolio. Looking into a marijuana ETFs performance and its assets can allow you to find the best ones to invest in. In addition, following how these ETFs behave in the market can help you find the best entry point for your position. As we continue to see the cannabis sector reach new lows let’s look at 4 cannabis ETFs for your list in 2022.
Best Marijuana ETFs For Your 2022 Watchlist
- AdvisorShares Pure US Cannabis ETF (NYSEArca: MSOS)
- The Cannabis ETF (NYSEAcra: THCX)
- AdvisorShares Pure Cannabis ETF (NYSEArca: YOLO)
- Amplify Seymour Cannabis ETF (NYSEArca: CNBS)
The AdvisorShares Pure US Cannabis ETF (MSOS)
The AdvisorShares Pure US Cannabis ETF is the first marijuana ETF to exceed $1 billion in assets under management in the United States. In general, this top marijuana ETF’s holdings and assets are mostly focused on US cannabis companies. Vertically integrated multi-state operators in the United States, leading cannabis REITs in the United States, CBD companies, pharmaceutical companies, and hydroponic suppliers make up the majority of the ETF’s assets. MSOS ETFs currently own Trulieve Cannabis Corp. (TCNNF), Curaleaf Holdings, Inc. (CURLF), Green Thumb Industries Inc. (GTBIF), and Cresco Labs Inc. (OTC: CRLBF).
MSOS ETF ended at $21.42 on January 21st, down 4.16 % for the day. This ETF is down 42.88 % in the previous six months, with a 52-week price range of $21.20-$55.91. AdvisorShares added a psychedelics ETF, AdvisorShares Psychedelics ETF (NYSEAcra: PSIL), to its ever-expanding range of holdings in September. Currently, the MSOS ETF does not pay a dividend.
The Cannabis ETF (THCX)
The Cannabis ETF (THCX) tracks the Innovation Labs Cannabis Index, which provides investors with global exposure to cannabis, hemp, CBD, and pharmaceutical-based cannabis companies. The fund’s assets are invested primarily in the United States and Canada, with a focus on medicines and a combination of value and growth cannabis companies. The THCX ETF’s top holdings include Village Farms International, Inc., Tilray, Inc., GrowGeneration Corp. (NASDAQ: GRWG), and Amyris (NASDAQ: AMRS), Inc. This ETF might give investors a lot of exposure to the Canadian and medical portions of the business, as well as other leading ancillary companies.
THCX ETF has been down 52.88 % in the previous six months, with a 52-week range of $7.18-$30.99. Currently, THCX ETF ended at $7.25 on January 21st, down 18.49 % in the previous month. THCX ETF is now down 11.13 % in the last five trading days.
AdvisorShares Pure Cannabis ETF YOLO
The company’s other top cannabis ETF, AdvisorShares Pure Cannabis ETF, or YOLO ETF invests in both local and worldwide cannabis stock assets in the hopes of long-term wealth gain. Among the ETF’s holdings are Village Farms International, Inc. (NASDAQ: VFF), Canopy Growth Corporation (NASDAQ: CGC), and Tilray Inc. (NASDAQ: TLRY). In essence, this ETF would give investors with exposure to some of the most well-known cannabis companies in both the United States and Canada.
With a 52-week price range of $10.35-$31.87, the YOLO ETF has lost 46.25 % in the previous six months. The stock ended at $10.46 on January 21st, down 11.88 percent in the previous five trading days. In 2022 the YOLO ETF may be a smart method for investors to obtain exposure to the global cannabis sector. In addition to certain Canadian cannabis companies, the YOLO ETF contains around 61.5 percent of its weight in marijuana equities from the United States.
Amplify Seymour Cannabis ETF (CNBS)
With more than 80% of its assets in companies that generate revenue from cannabis and hemp cultivation, the Amplify Seymour Cannabis ETF gives investors exposure to the global cannabis market. This cannabis ETF has stated that it can access US MSOs through swaps. CNBS ETF now holds major positions in Green Thumb Industries, Curaleaf Holdings, WM Technology, Inc. (NASDAQ: MAPS), and Hydrofarm Holdings Group, Inc., thanks to the inclusion of US cannabis firms (NASDAQ: HYFM). Tilray, Inc. and Village Farms International, Inc. are two more companies in which he has invested.
On January 21st, the CNBS ETF finished at $11.95 after losing 12.52 percent in the previous month. The ETF is down 48.58 percent in the last six months, with a 52-week price range of $11.85-$40.65. At the present time, the Amplify Seymour Cannabis ETF pays a $0.10 yearly dividend, for a dividend yield of 0.49%. Amplify ETFs’ total assets under management surpassed $5 billion in November.